Related references
Note: Only part of the references are listed.Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells
Xiaoyan Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells
Jennifer J. Schumacher et al.
CANCER RESEARCH (2007)
Abl-SH3 binding protein 2, 3BP2, interacts with CIN85 and HIP-55
Severine Le Bras et al.
FEBS LETTERS (2007)
Novel Abl kinase inhibitors in chronic myeloid leukemia in blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia
Ronan Swords et al.
CLINICAL LYMPHOMA & MYELOMA (2007)
Cooperation between VEGF and β3 integrin during cardiac vascular development
Sara M. Weis et al.
BLOOD (2007)
Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas
Nathan D. Price et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo
Houda Jallal et al.
CANCER RESEARCH (2007)
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: By the GIMEMA working party on chronic myeloid leukemia
Simona Soverini et al.
CLINICAL CANCER RESEARCH (2006)
VEGF, a prosurvival factor, acts in concert with TGF-β1 to induce endothelial cell apoptosis
Giovanni Ferrari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells
Lingfang Zeng et al.
JOURNAL OF CELL BIOLOGY (2006)
Characterization of an imatinib-sensitive subset of high-grade human glioma cultures
D. Hagerstrand et al.
ONCOGENE (2006)
Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors
JZ Sun et al.
ONCOGENE (2005)
Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis
R Shao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth
RG Fahmy et al.
NATURE MEDICINE (2003)
Role of Raf in vascular protection from distinct apoptotic stimuli
A Alavi et al.
SCIENCE (2003)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling
BP Eliceiri et al.
JOURNAL OF CELL BIOLOGY (2002)
The focal adhesion kinase - A regulator of cell migration and invasion
CR Hauck et al.
IUBMB LIFE (2002)
Integrin and growth factor receptor crosstalk
BP Eliceiri
CIRCULATION RESEARCH (2001)
Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway
A Echarri et al.
CURRENT BIOLOGY (2001)
Vascular-specific growth factors and blood vessel formation
GD Yancopoulos et al.
NATURE (2000)
FAK integrates growth-factor and integrin signals to promote cell migration
DJ Sieg et al.
NATURE CELL BIOLOGY (2000)